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with the DPD impacts outcomes.
Methods: Between 2/2000 – 3/2003, 551 pts with carotid disease had 588 procedures of
CAS. All clinical variables, technical details, and results were documented prospectively.
Clinical outcomeswere prospectively monitored for 30 days post procedure.
Results: In 45 (7.7%) procedures the lesion was pre-dilated before DPD deployment,
using 1.5-2mm diameter balloon. In 40 (89%) of them, the reminder of the procedure,
including DPD and stent placements, were successful. One patient had a “string” sign, so
no further intervention was attempted. In one patient DPD was successfully deployed,
but the stent could not be placed due to severe proximal tortuousity. In 3 cases, a filter-
based DPD could not cross the stenosis despite pre-dilatation. In 1 of them, distal bal-
loon-based DPD and stent were successfully deployed. The other two had stenting with-
out embolic protection. There were no strokes or mortality in the pre-dilatation group pts.
Conclusion: 1. Balloon pre-dilatation prior to DPD placement was needed in very tight
and complex lesions, and enabled a DPD system to cross the lesion in 96% of these
cases. 2. Balloon pre-dilatation prior to DPD placement was safe, and was not associ-
ated with any major adverse events.
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Background: In order to understand the risk of carotid angiography performed by inter-
ventional cardiologists with peripheral vascular training, we undertook a retrospective
study to determine the neurological complications in patients who underwent selective
cerebral angiography.
Methods: Neurological complications were considered related to angiography when they
occurred within 24 hours of the procedure. Hospital records were reviewed to determine
any in-hospital neurological complications following carotid and cerebral angiography.
Results: A total of 483 consecutive patients underwent aortic arch and 4-vessel cerebral
angiography. Almost 2/3 of patients were symptomatic. A total of 200/483 (41%) of
patients also underwent coronary angiography at the same setting. There was one tran-
sient ischemic attack. There were no minor or major strokes, or death.
Conclusion: Experienced interventional cardiologists can perform diagnostic aortic arch
and selective carotid and vertebral angiography in the cardiac catheterization laboratory
with a very low complication rate. This will be important as cardiologists begin to manage
more patients with peripheral vascular disease, and carotid stenting emerges as a viable
option for high-risk patients in need of carotid revascularization.
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Recently, stenting (S) has been shown to improve outcomes compared with endarterec-
tomy (CEA) for high risk patients undergoing carotid revascularization. The true costs
and cost-effectiveness of these alternative treatment strategies are unknown.
Methods: We prospectively measured medical resource utilization and cost for all 334
pts who were randomized to S or CEA in the SAPPHIRE trial. Procedural costs were
based on measured resource utilization and current unit costs, while all other costs were
estimated from hospital charges and hospital-specific cost-to-charge ratios.
Results: The primary endpoint of death, MI, or stroke at 30 days was reduced by 50%
with S compared with CEA (4.8% vs. 9.6%, p=0.14). Compared with CEA, S was associ-
ated with shorter initial procedures and reduced post-procedure length of stay by ~1 day
(see Table). As a result, S reduced hospital costs (excluding study devices) by more than
$1200/pt and physician fees by ~$750/pt (p<0.001 for both). Nonetheless, when the
costs of study devices were included, initial treatment costs were actually $813/pt higher
with S. Full 1-year economic data and formal cost-effectiveness analysis will be available
by 3/04.
Conclusions: Although S was associated with shorter procedures and lengths of stay
than CEA, initial costs were increased modestly in this high risk population. The cost-
effectiveness of S will thus depend on its ability to reduce follow-up medical care costs, to
provide sustained reductions in major complications, or both.
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Background: Doppler ultrasonography is widely accepted as a means of non-invasively
estimating internal carotid artery (ICA) stenosis. However, the utility of Doppler ultra-
sonography for assessing in-stent restenosis (ISR) after internal carotid stenting (CS)
has not been well studied. We examined the relationship between Doppler ultrasound cri-
teria and angiographic restenosis in patients after CS.
Methods: Two hundred and thirty-five patients who underwent CS at our institution and
had a follow-up Doppler study done at a minimum of 5 months after the index procedure
were studied. Patients with high-grade contralateral stenosis or occlusions were
excluded. Twenty-four consecutive patients were identified who had > 60% Doppler-
defined ISR on follow-up exam (60-79%: PSV>150 cm/sec, EDV<cm/sec; 80-99%: >150
cm/sec, EDV>135 cm/sec). These patients subsequently underwent diagnostic carotid
angiography. The PSV, EDV, and ICA/CCA ratio among patients who had true angio-
graphic ISR were compared with those who did not.
Results: True ISR (>50% by quantitative coronary angiography) was present in 8/24
patients (33.3%), while 16/24 patients (66.6%) did not have ISR by angiography. The
median PSV (range: 152-427 cm/sec) and EDV (range: 34-200 cm/sec) for the entire
cohort were 231 cm/sec and 65 cm/sec, respectively. The median PSV and EDV were
significantly higher among patients with true angiographic ISR as compared to those
without angiographic ISR (PSV: 350 cm/sec vs. 201 cm/sec, p=0.004; EDV: 139 cm/sec
vs. 54 cm/sec, p=0.006). Furthermore, the median ICA/common carotid artery (CCA)
ratio was significantly higher among patients with true angiographic restenosis as com-
pared to those without (3.92 vs 1.62, p=0.009).
Conclusions: Among patients with carotid stents, current Doppler criteria for defining
restenosis are not accurate. Modified Doppler criteria with higher thresholds for PSV and
EDV, as well as the use of ICA/CCA ratios are more appropriate for assessing ISR after
CS.
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Purpose. Our objective was to evaluate immediate and long-term results of carotid
angioplasty and stenting and the clinical impact of cerebral protection systems. Materi-
als/Methods. From June 1997 to June 2003 a total of 674 patients (mean age 71 ±7,6)
underwent carotid stenting for carotid stenosis.
Results. Primary technical success achieved in 672/674 (99,70%). Procedure failures
were two. One for entrapment of Angioguard wire in the proximal edge of a Palmaz stent
treated by surgical cut-down without complications and the second one due to a spiral
dissection of internal carotid caused by Percusurge occlusive balloon. Twenty-eight
(4,17%) patients had symptomatic complications : 1 (0,15%) death, 2 (0,30%) major
stroke, 9 (1,34%) minor stroke, 8 (1,19%) intracranial hemorrhage, 7 (1,04%) TIA and 1
(0,15%) arterial wall perforation. . In hospital and 30-days complications in protected
group (547 patients) was: 1 (0,18%)death, 2 (0,37%) major stroke, 6 (1,10%) minor
stroke, 7 (1,28%) intracranial hemorrhage, 6 (1,10%) TIA and 1 (0,18%) arterial wall per-
foration. Embolic complications rate in protected group was 15 (2,75%). We used :
Angioguard 236 (43,14%), Mednova Neuroshield 95 (17,37%), Trap-filter 67 (12,25%),
Percusurge 26 (4,75%), MOMA 20 (3,66%), Accunet 15 (2,74%), Parodi System 7
(1,28%). Complications related to the use of embolic protection devices were: two
(0,37%) dissection treated with an additional stent, one (0,18%) vessel occlusion by spi-
ral dissection, one (0,18%) “trapped” guidewire.
Long-term outcome (range 3 months-72 months) was concluded in 510 patients. Patients
free for major and minor neurologic events was 471 (92,35%). Complications: neurologi-
cal death 4 (0,78%), major ipsi-lateral non-fatal stroke 2 (0,39%), minor ipsi-lateral non-
fatal stroke 0 (0%), stent crush 1 (0,20%), stent migration 2 (0,39%), death (other
causes) 17 (3,33%). Color-Doppler follow up examination showed 13 (2,55%) asymptom-
atic restenosis (⊇ 50%).
Conclusion. our results suggested that carotid angioplasty and stenting is a safe in term
of early and long term results. Cerebral protection devices appears effective.
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Background: Hypotension is common following carotid artery stenting (CAS), and may be
mediated by vagal stimulation and/or suppression of spinal sympathetic outflow. Both
mixed α/β agonists dopamine (DA) and more selective α-agonists (norepinephrine (NE)
and phenylephrine (PE)) have been used, but the most effective treatment of post-CAS
hypotension is unknown. Methods: We analyzed data for consecutive patients requiring
vasopressor treatment of post-CAS hypotension. Choice of vasopressor was made by
the treating physician. Endpoints included infusion duration, coronary care unit (CCU)
length of stay (LOS), TIA, new arrhythmia, cardioversion, angina, and any major adverse
event. Results: Over 5 years, CAS stenting was performed in 438 patients. CCU admis-
sion, in atropine non-responders, for vasopressor treatment was required in 42 patients
(9.6%): DA in 20 patients (48%), NE in 13 patients (31%), and PE in 9 patients (21%).
Vasopressor infusion time was 31.8 ± 10.6 h for DA, compared with 23.8 ± 8.1 h for NE
(p=0.052) and 22.2 ± 6.1 h for PE (p=0.028). CCU LOS was 46.5 ± 14.1 h for DA com-
pared with 36.9 ± 9.1 h for the NE and PE groups combined (p=0.056). Adverse events
are listed in the Table. Major adverse events were more common among patients receiv-
Initial Hospital Resource Utilization and Costs
Stent group 
(n=167)
Endarterectomy 
group (n=167)
Difference (95% CI) P-
value
Procedure duration 
(hours)
1.3 ± 0.6 3.0 ± 1.1 -1.6 (-1.8, -1.4) <0.001
Length of stay (days) 1.9 ± 2.0 2.8 ± 3.6 -0.9 (-1.6, -0.3) <0.001
Device costs $2741 ± 710 $35 ± 307 $2706 (2583, 2829) <0.001
Other hospital costs $5949 ± 3475 $7175 ± 4801 -$1226 (-2155, -297) <0.001
Physician costs $2104 ± 294 $2850 ± 567 -$746 (-845, -646) <0.001
Total Cost $10,794±3635 $9980 ± 4775 $813 (-128, 1755) 0.09
